Not applicableStudy completedNCT02616913What this trial is testingEvaluation of the Cardiac Effects of a Novel Food Ingredient in Healthy Male SubjectsWho this might be right forCardiovascular Abnormalities Cargill 48
Testing effectiveness (Phase 2)Study completedNCT01321723What this trial is testingPharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal WomenWho this might be right forPostmenopausal Osteoporosis Unigene Laboratories Inc. 97
Large-scale testing (Phase 3)Active Not RecruitingNCT06125951What this trial is testingEffect of 10 mg Xanamem on Dementia Due to Alzheimer's DiseaseWho this might be right forDementia ModerateDementia, MildAlzheimer Disease Actinogen Medical 247
Large-scale testing (Phase 3)Study completedNCT01610700What this trial is testingAn Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis PatientsWho this might be right forMultiple Sclerosis Jazz Pharmaceuticals 160
Early research (Phase 1)Study completedNCT05310032What this trial is testingInvestigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HSG4112 in High DosesWho this might be right forObesity Glaceum 36
Post-approval studies (Phase 4)Study completedNCT04041284What this trial is testingEvaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive DisorderWho this might be right forMigraineMajor Depressive Disorder Teva Branded Pharmaceutical Products R&D, Inc. 353
Large-scale testing (Phase 3)Study completedNCT00411242What this trial is testingEfficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive DisorderWho this might be right forMajor Depressive Disorder (MDD) Novartis 503
Testing effectiveness (Phase 2)Study completedNCT00591409What this trial is testingA Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part A: Japanese Participants (P05956)Who this might be right forAnesthesia, General Merck Sharp & Dohme LLC 100
Not applicableUnknownNCT05152407What this trial is testingMRB 0.3% Serum Effectiveness on 2 Early Clinical Markers of Photoinduced Cutaneous Aging: Actinic Lentigo and Actinic KeratosisWho this might be right forActinic KeratosisActinic Lentigo NAOS Institute of Life Science 35
Not applicableStudy completedNCT00379236What this trial is testingThe Efficacy and Safety of EUFLEXXA™ for Treatment of Painful Osteoarthritis of the KneeWho this might be right forOsteoarthritis, Knee Ferring Pharmaceuticals 588
Large-scale testing (Phase 3)Study completedNCT03658616What this trial is testingAssessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis.Who this might be right forPrimary Axillary Hyperhidrosis Dr. August Wolff GmbH & Co. KG Arzneimittel 518
Post-approval studies (Phase 4)Study completedNCT02201004What this trial is testingTOFO Insulin Combination TrialWho this might be right forType 2 Diabetes Mellitus Sanofi 211
Large-scale testing (Phase 3)Study completedNCT00645307What this trial is testingA 52 Week Open Label Extension Trial Following the Recurrence Prevention Study R076477-SCH-301 to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia.Who this might be right forSchizophrenia Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 235
Testing effectiveness (Phase 2)Study completedNCT01023685What this trial is testingTo Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's PatientsWho this might be right forAlzheimer Disease Novartis 24
Testing effectiveness (Phase 2)Study completedNCT01004016What this trial is testingKPS-0373 in Patients With Spinocerebellar Degeneration (SCD)Who this might be right forSpinocerebellar Degeneration Kissei Pharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT04261387What this trial is testingLUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer PatientsWho this might be right forRadiation Dermatitis Lutris Pharma Ltd. 28
Testing effectiveness (Phase 2)Ended earlyNCT02975349What this trial is testingEfficacy and Safety of M2951 in Participants With Relapsing Multiple SclerosisWho this might be right forRelapsing-remitting Multiple Sclerosis EMD Serono Research & Development Institute, Inc. 267
Testing effectiveness (Phase 2)UnknownNCT05240131What this trial is testingInvestigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC).Who this might be right forNon-Small Cell Lung Cancer Galecto Biotech AB 88
Early research (Phase 1)Study completedNCT06193031What this trial is testingEvaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy ParticipantsWho this might be right forHealthy Volunteers Insmed Incorporated 24
Testing effectiveness (Phase 2)Study completedNCT00270283What this trial is testingEvaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) TherapyWho this might be right forAcquired Immunodeficiency SyndromeAnemia Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 102